LC Sciences has developed a customized solution to high-throughput genome wide variant analysis. The VariantPro™ system is comprised of three distinct innovations, all developed by scientists at LC Sciences: Relay-PCR™, Omega Primers™ and OligoMix®. A full commercial launch of this technology is expected Q4, 2015. Currently, LC Sciences is seeking beta testers for early access […]
Upcoming conferences, webinars, workshops and presentations.
All the latest news in the world of Exome Sequencing.
Featured job openings in the field of Exome Sequencing
Whole-exome sequencing (WES) has become the strategy of choice to identify causal variants in monogenic disorders. However, the list of candidate variants can be quite large, including false positives generated by sequencing errors. To reduce this list of candidate variants to the most relevant ones, a cost-effective strategy would be to focus on regions of […]
Personal Genome Diagnostics Collaborates on Study Uncovering New Actionable Mutations and Prognostic Predictors in Pancreatic Cancer Study in Nature Communications Identifies New Predictors of Patient Outcome and Suggests Targeted Therapy Approaches May Benefit More Patients than Previously Thought Study Also Demonstrates Liquid Biopsies of Cell-Free Tumor DNA in Blood Can Detect Early Stage Pancreatic Cancer […]
Deanna Church – Senior Director of Genomics & Content Technological advances in high throughput, low cost DNA sequencing coupled with the availability of a high quality reference assembly allow us to interrogate the genome with greater precision than ever before. Together with increased understanding of the genetic underpinnings of disease, these advances mean our success […]
Acute liver failure is a rare yet life-threatening disease for young children. It often occurs extremely rapidly, for example, when a child has a fever. Yet in around 50 percent of cases it is unclear as to why this happens. Now, a team of researchers working on an international research project headed by Technische Universität […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced new additions to its market-leading SureSelect target-enrichment product family, which has already enabled researchers to identify more than 50 Mendelian disease-causing genes. “This latest design, optimized to cover targeted regions in greater detail, can also be blended with any custom capture design, enabling an exome tailored […]